Skip to main content
OpenTrials

Clinical trial condition

Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma

Explore clinical trials studying Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma trial results

Active, Not Recruiting

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

NCT03598998

Conditions
Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions